Verastem, Inc. (VSTM)
7.72
-0.46
(-5.62%)
USD |
NASDAQ |
Nov 16, 16:00
7.72
0.00 (0.00%)
After-Hours: 19:55
Verastem Debt to Equity Ratio : 12.73 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 12.73 |
| June 30, 2026 | 1.687 |
| March 31, 2026 | 1.045 |
| December 31, 2025 | 1.524 |
| September 30, 2025 | -5.763 |
| June 30, 2025 | 2.350 |
| March 31, 2025 | -2.368 |
| December 31, 2024 | -1.462 |
| September 30, 2024 | 1.286 |
| June 30, 2024 | 1.046 |
| March 31, 2024 | 1.136 |
| December 31, 2023 | 0.5292 |
| September 30, 2023 | 0.4725 |
| June 30, 2023 | 0.407 |
| March 31, 2023 | 0.8572 |
| December 31, 2022 | 0.5711 |
| September 30, 2022 | 0.4312 |
| June 30, 2022 | 0.5038 |
| March 31, 2022 | 0.3736 |
| December 31, 2021 | 0.0363 |
| September 30, 2021 | 0.0347 |
| June 30, 2021 | 0.267 |
| March 31, 2021 | 0.2245 |
| December 31, 2020 | 0.1955 |
| September 30, 2020 | 0.4635 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.5211 |
| March 31, 2020 | 0.4802 |
| December 31, 2019 | 14.99 |
| September 30, 2019 | 6.510 |
| June 30, 2019 | 2.795 |
| March 31, 2019 | 1.424 |
| December 31, 2018 | 0.9691 |
| September 30, 2018 | 0.2329 |
| June 30, 2018 | 0.1963 |
| March 31, 2018 | 0.3868 |
| December 31, 2017 | 0.2571 |
| September 30, 2017 | 0.057 |
| June 30, 2017 | 0.0475 |
| March 31, 2017 | 0.0372 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 27.84 |
| Cytokinetics, Inc. | -3.962 |
| Inovio Pharmaceuticals, Inc. | -0.2147 |
| Rigel Pharmaceuticals, Inc. | 0.0175 |
| United Therapeutics Corp. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 229.64M |
| Total Liabilities (Quarterly) | 219.54M |
| Shareholders Equity (Quarterly) | 10.10M |
| Current Ratio | 1.930 |
| Net Debt Paydown Yield | -1.15% |